Schrödinger Inc.
New York, NY · United States
Specialization: Computational drug design, physics-based simulation, AI/ML
Key Differentiator
World leader in computational drug design
Core Services
Physics-based molecular simulation; FEP+ (free energy perturbation); Computational chemistry platform; AI/ML drug design; Internal drug pipeline (TYK2, CDC7, etc.)
Capabilities
Market Intelligence
World leader in computational drug design. Physics+AI platform. NASDAQ-listed. TYK2 → Phase III.
Website
https://www.schrodinger.comSimilar Companies
Aragen Life Sciences (US)
Waltham, MA (US); Hyderabad, India (HQ) · Discovery chemistry & biology, DMPK
Growing discovery CRO
BioDuro-Sundia
Irvine, CA (HQ); San Diego, CA; China · Integrated discovery→manufacturing CRDMO
US-HQ CRDMO
Charles River Laboratories
Wilmington, MA (HQ); 150+ locations in 21 countries · GLP toxicology, safety assessment, ADME/DMPK
WORLD'S LARGEST preclinical CRO
Charles River Laboratories (Canada)
Senneville, QC; Sherbrooke, QC; Laval, QC · Drug discovery, safety assessment, DMPK, biologics testing, viral vector manufacturing
World's largest preclinical CRO — major Canadian operations across Quebec
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.